(Q47950786)

7 February 2018

title

Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes (English)

1 reference

7 February 2018

5

Thomas A Wynn

1 reference

7 February 2018

author name string

Jonathan M Swartz

1

1 reference

7 February 2018

Jonas Byström

2

1 reference

7 February 2018

Kimberly D Dyer

3

1 reference

7 February 2018

Takeaki Nitto

4

1 reference

7 February 2018

Helene F Rosenberg

6

1 reference

7 February 2018

publication date

26 July 2004

1 reference

7 February 2018

Journal of Leukocyte Biology

published in

1 reference

7 February 2018

volume

76

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

812-819

1 reference

7 February 2018

Eosinophils: 'new' roles for 'old' cells

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Eosinophil function in allergic inflammation: from bone marrow to tissue response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The role of eosinophils in host defense against helminth parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The role of eosinophils in parasitic helminth infections: insights from genetically modified mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Do eosinophils have a role in the killing of helminth parasites?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Verdict in the case of therapies versus eosinophils: the jury is still out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Tumour-associated eosinophilia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

A role for eosinophils in transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Immunology of respiratory syncytial virus infection: eosinophils, cytokines, chemokines and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The eosinophil ribonucleases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Eosinophil Major Basic Protein Stimulates Neutrophil Superoxide Production by a Class IA Phosphoinositide 3-Kinase and Protein Kinase C-ζ-Dependent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Gene microarray analysis reveals interleukin-5-dependent transcriptional targets in mouse bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The plasminogen activator system: biology and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The urokinase-type plasminogen activator system in prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The plasminogen activation system in tumor growth, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Receptor-bound uPA is reversibly protected from inhibition by low molecular weight inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The AML14 and AML14.3D10 cell lines: a long-overdue model for the study of eosinophils and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Plasminogen activator-specific inhibitors produced by human monocytes/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Expression of matrix metalloproteinases MMP-9 within the airways in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Clinical findings, bronchoalveolar lavage fluid cytology and matrix metalloproteinase-2 and -9 in canine pulmonary eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Human eosinophils are activated by cysteine proteases and release inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Expression of and functional responses to protease-activated receptors on human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Inhibitory role of eosinophils on cell surface plasmin generation by bronchial epithelial cells: inhibitory effects of transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Airway remodeling in asthma: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Airway wall remodeling: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Inhibition of airway remodeling in IL-5-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Plasminogen activator inhibitor-1 in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0304182

21 January 2018

Identifiers

DOI

10.1189/JLB.0304182

1 reference

7 February 2018

PubMed ID

15277569

1 reference

7 February 2018